» Articles » PMID: 16084708

Immunogenetics of Viral Infections

Overview
Publisher Elsevier
Date 2005 Aug 9
PMID 16084708
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

The HLA class I and II genes encode molecules that lie at the heart of the acquired immune response against infectious diseases. Associations between these polymorphic loci and genetically complex infectious diseases have been historically elusive, in contrast to the more obvious HLA associations with autoimmune diseases. High resolution molecular typing of large, clinically well-defined cohorts has begun to uncover evidence for the influence of HLA diversity on diseases of viral etiology, such as those caused by HIV-1, hepatitis B virus, hepatitis C virus and human papilloma virus. Combinations of HLA and KIR also appear to affect outcome to viral infection, supporting a role for HLA class I diversity in the innate immune response in addition to the acquired immune response.

Citing Articles

The Influence of HLA Polymorphisms on the Severity of COVID-19 in the Romanian Population.

Vica M, Dobreanu M, Curocichin G, Matei H, Balici S, Vuscan M Int J Mol Sci. 2024; 25(2).

PMID: 38279325 PMC: 10816224. DOI: 10.3390/ijms25021326.


Association between Human Leukocyte Antigen (HLA) DQB1*06 and HLA DQB1*03 and adverse outcomes in a group of critically ill patients with COVID-19 in Tunisia: a cross-sectional study.

Ben Bnina A, El Bahri Y, Cheybi A, Ben Lazrek N, Chouchane S, Omezzine A Pan Afr Med J. 2023; 45:109.

PMID: 37719057 PMC: 10504440. DOI: 10.11604/pamj.2023.45.109.39956.


The New Kid on the Block: HLA-C, a Key Regulator of Natural Killer Cells in Viral Immunity.

Vollmers S, Lobermeyer A, Korner C Cells. 2021; 10(11).

PMID: 34831331 PMC: 8620871. DOI: 10.3390/cells10113108.


The Role of Immunogenetics in COVID-19.

Pojero F, Candore G, Caruso C, Di Bona D, Groneberg D, Ligotti M Int J Mol Sci. 2021; 22(5).

PMID: 33807915 PMC: 7961811. DOI: 10.3390/ijms22052636.


Exploring Host Genetic Polymorphisms Involved in SARS-CoV Infection Outcomes: Implications for Personalized Medicine in COVID-19.

Ramos-Lopez O, Daimiel L, Ramirez de Molina A, Martinez-Urbistondo D, Vargas J, Martinez J Int J Genomics. 2020; 2020:6901217.

PMID: 33110916 PMC: 7582067. DOI: 10.1155/2020/6901217.